Baroreflex activation therapy in patients with heart failure with reduced ejection fraction: a single‐centre experience
Abstract Aims Heart failure with reduced ejection fraction (HFrEF) is associated with excessive sympathetic and impaired parasympathetic activity. The Barostim Neo™ device is used for electronical baroreflex activation therapy (BAT) to counteract autonomic nervous system dysbalance. Randomized trial...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Oxford University Press
2023-12-01
|
| Seri Bilgileri: | ESC Heart Failure |
| Konular: | |
| Online Erişim: | https://doi.org/10.1002/ehf2.14508 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|